Framatome, KHNP to investigate producing Lu-177 in South Korea

April 19, 2024, 7:01AMNuclear News
Catherine Cornand of Framatome and Chang Hee-Seung of KHNP (center) with Framatome and KHNP employees following the signing of the MOU. (Photo: Framatome)

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at KHNP’s Wolsong nuclear power plant in South Korea. The companies also will investigate the feasibility of using the plant to support Korean production of medical radioisotopes in the future.

To continue reading, log in or create a free account!

Related Articles

Nuclear's future discussed at MURR expansion

April 7, 2025, 3:05PMANS News

ANS Executive Director/CEO Craig Piercy recently spoke on nuclear power’s potential for answering today’s energy demands as part of the Distinguished Lecture Series at the University of...

US, Korea sign MOU for nuclear cooperation

January 14, 2025, 3:14PMNuclear News

The U.S. departments of Energy and State have signed a memorandum of understanding with the Republic of Korea’s ministries of Trade, Industry and Energy and of Foreign Affairs for the two...

NRC schedules Atlanta meeting

October 22, 2024, 7:01AMNuclear News

A hybrid public meeting hosted by the Nuclear Regulatory Commission on October 30 will feature chair Christopher Hanson and commissioners David Wright, Annie Caputo, and Bradley Crowell....